EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Expression of Apolipoprotein L1 Risk Variants at the Plasma Membrane and Haplotype-Dependent Cytotoxicity

Oyindamola Christiana Adebayo iD, Ilhem Dallali iD, Sara Kerselaers iD, Sergio Gimeno-Rocafort, Sandra Van Aerschot, Annelies Janssens iD, Tjessa Bondue iD, Charlotte Cresens iD, Nnamdi Joseph Asouzu, Nikky Corthout iD, Rik Gijsbers iD, Elena N Levtchenko iD und 3 weitere

Journal of the American Society of Nephrology · 2026-11 · 37 (11) · 2450-2469

DOI: 10.1681/asn.0000001159 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, online erschienen am 15.06.2026. Verfasst von Oyindamola Christiana Adebayo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium. Hauptthemen laut MEDLINE: Apolipoprotein L1, Cell Membrane. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fonds Wetenschappelijk Onderzoek, KU Leuven, CSL Behring.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key Points Apolipoprotein L1 variants were transported to the plasma membrane via actin filaments, where they exhibited distinct dynamics. Apolipoprotein L1 was functionally expressed at the plasma membrane and formed a voltage-dependent non-selective cation-permeable pore. Influx of calcium from the extracellular medium was the primary origin of the increased cytosolic calcium crucial for Apolipoprotein L1 cytotoxicity.

Background

The mechanisms by which apolipoprotein L1 ( APOL1 ) risk variants, G1 and G2, induce kidney disease in individuals of African ancestry remain contentious.

Methods

In this study, we utilized a heterologous expression system of HEK-293 cells and human podocytes to investigate APOL1-mediated cytotoxicity using genetic, electrophysiological, and microscopy-based approaches.

Results

APOL1 variants showed dynamic transport in vesicle-like structures toward the plasma membrane via actin filaments. At the plasma membrane, the non-risk APOL1 G0 and risk variants formed non-selective cation-permeable pores for Na + and Ca 2+ , exhibiting functional activity under basal conditions. Extracellular Ca 2+ was identified as the primary source of Ca 2+ influx through APOL1, leading to cytotoxicity. APOL1 risk variants exhibited increased basal channel activity compared to non-risk APOL1 G0, resulting in haplotype-dependent cytotoxicity. Furthermore, we observed that both the M1 (N264K) variant and APOL1 inhibitor, Inaxaplin, exerted protective effects on cell viability by blocking the APOL1-dependent intracellular Ca 2+ influx.

Conclusions

This study demonstrated APOL1 to be a membrane protein involved in the influx of Ca 2+ from the extracellular medium. Increased activity of APOL1 led to markedly increased cytotoxicity, which supports the gain-of-function theory. This effect was prevented by the presence of N264K variant or treatment with the APOL1 inhibitor, Inaxaplin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Apolipoprotein L1Cell MembraneHumansHEK293 CellsHaplotypesPodocytesCalcium

Stichwörter der Autor:innen

apolipoprotein L1 (APOL1)

Substanzen

Apolipoprotein L1APOL1 protein, humanCalcium

Autor:innen und Institutionen

  • Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium.
  • Department of Development and Regeneration, Laboratory of Pediatric Nephrology, KU Leuven, Leuven, Belgium.
  • Department of Development and Regeneration, Implantation, Placentation, Pregnancy, and Endometriosis Research group (POPPYe), KU Leuven, Leuven, Belgium.
  • Department of Cellular and Molecular Medicine, Laboratory of Ion Channel Research, KU Leuven, Leuven, Belgium.
  • VIB-KU Leuven Center for Brain and Disease Research, KU Leuven, Leuven, Belgium.
  • VIB Bio Imaging Core and VIB-KU Leuven Center for Brain and Disease Research, KU Leuven, Leuven, Belgium.

ORCID-Profile: Oyindamola Christiana Adebayo, Ilhem Dallali, Sara Kerselaers, Annelies Janssens, Tjessa Bondue, Charlotte Cresens, Nikky Corthout, Rik Gijsbers, Elena N Levtchenko, Lambertus van den Heuvel, Joris Vriens, Veerle Labarque

Förderung

  • Fonds Wetenschappelijk Onderzoek
  • KU Leuven
  • CSL Behring
  • Abacus

Zitieren

APA

Adebayo, O. C., Dallali, I., Kerselaers, S., Gimeno-Rocafort, S., Van Aerschot, S., Janssens, A., Bondue, T., Cresens, C., Asouzu, N. J., Corthout, N., Gijsbers, R., Levtchenko, E. N., van den Heuvel, L., Vriens, J., & Labarque, V. (2026). Expression of Apolipoprotein L1 Risk Variants at the Plasma Membrane and Haplotype-Dependent Cytotoxicity. Journal of the American Society of Nephrology, 37(11), 2450-2469. https://doi.org/10.1681/asn.0000001159

Vancouver

Adebayo OC, Dallali I, Kerselaers S, Gimeno-Rocafort S, Van Aerschot S, Janssens A, et al. Expression of Apolipoprotein L1 Risk Variants at the Plasma Membrane and Haplotype-Dependent Cytotoxicity. Journal of the American Society of Nephrology. 2026;37(11):2450-2469. doi:10.1681/asn.0000001159

BibTeX
@article{Adebayo2026,
  author = {Adebayo, Oyindamola Christiana and Dallali, Ilhem and Kerselaers, Sara and Gimeno-Rocafort, Sergio and Van Aerschot, Sandra and Janssens, Annelies and Bondue, Tjessa and Cresens, Charlotte and Asouzu, Nnamdi Joseph and Corthout, Nikky and Gijsbers, Rik and Levtchenko, Elena N and van den Heuvel, Lambertus and Vriens, Joris and Labarque, Veerle},
  title = {Expression of Apolipoprotein L1 Risk Variants at the Plasma Membrane and Haplotype-Dependent Cytotoxicity},
  journal = {Journal of the American Society of Nephrology},
  year = {2026},
  volume = {37},
  number = {11},
  pages = {2450--2469},
  doi = {10.1681/asn.0000001159}
}
Kostenlos starten →